Discovery MI Gen2 vs uPMR 790

Direct competitors — feature-level head-to-head below. Comparability 85/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by GE HealthCare
VS
by Shanghai United Imaging Healthcare Co.

AI Verdict

GE HealthCare's Discovery MI Gen2 is a PET/CT system leveraging deep-learning AI for enhanced diagnostic imaging, focusing on features like motion correction and reduced scan times. In contrast, Shanghai United Imaging Healthcare Co.'s uPMR 790 is a PET/MR system offering simultaneous, high-resolution imaging with AI-enhanced workflows. Both tools are direct competitors in providing advanced hybrid imaging for oncology, neurology, and cardiology, with the primary distinction being the choice between CT's speed and bone imaging capabilities versus MR's superior soft tissue contrast and lack of ionizing radiation.

Choose Discovery MI Gen2 if…

Choose Discovery MI Gen2 if your primary need is a highly efficient and precise digital PET/CT system that minimizes patient dose and scan times while maximizing image quality. Its deep-learning AI, TrueFidelity™ reconstruction, and MotionFree technology are ideal for facilities seeking superior small lesion detectability and robust motion correction in oncology, neurology, and cardiology PET/CT studies.

View Discovery MI Gen2 →

Choose uPMR 790 if…

Choose uPMR 790 if your institution requires the advanced capabilities of simultaneous PET/MRI imaging for comprehensive, high-resolution diagnostic and research applications. This system excels in providing co-registered anatomical and metabolic information with industry-leading PET spatial resolution and AI-enhanced MR acquisition, making it suitable for complex cases and cutting-edge research in oncology, neurology, and cardiology.

View uPMR 790 →

For a physician evaluating advanced imaging solutions, GE HealthCare’s Discovery MI Gen2 and Shanghai United Imaging Healthcare Co.’s uPMR 790 both offer cutting-edge AI-powered capabilities in oncology, neurology, and cardiology. The Discovery MI Gen2 is a digital PET/CT system that excels in delivering superior diagnostic imaging through deep-learning AI for image reconstruction, high sensitivity, and advanced motion correction. Its strengths lie in optimizing PET/CT workflows with features like reduced scan times and injected dose, and improved small lesion detectability. This system is ideal for practices prioritizing enhanced PET/CT image quality, quantitative accuracy, and operational efficiency.

In contrast, the uPMR 790 is a PET/MR system, offering simultaneous, high-resolution imaging by integrating PET and MRI technologies. Its key practical difference is this inherent multi-modality, providing comprehensive anatomical and metabolic information in a single scan. The uPMR 790 is best suited for physicians and researchers who require the complementary benefits of both PET and MRI, particularly for complex cases where soft tissue contrast from MRI combined with metabolic data from PET is crucial. Therefore, a physician focused on optimizing PET/CT performance and workflow would lean towards the Discovery MI Gen2, while those needing the integrated diagnostic power of simultaneous PET/MR imaging for advanced clinical and research applications would find the uPMR 790 more appropriate.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Discovery MI Gen2 uPMR 790
Pricing Contact vendor for pricing Not publicly available (high-end medical equipment)
Deployment On-premise (physical hardware) On-premise (installed in medical facilities)
FDA Status 1 AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Both tools emphasize intelligent workflow features and automation to enhance usability. Tool A highlights an 'Automated patient positioning system (Auto IN)' and 'Reduced scan times', while Tool B features 'Intelligent workflow features including automatic positioning, bed planning, and attenuation correction' and 'AI-enhanced workflows'. Both appear to prioritize ease of use and operational efficiency.

Clinical Value

uPMR 790

Tool B's primary advantage lies in its simultaneous PET/MR imaging capability, which offers comprehensive multimodal data in a single scan, potentially leading to more holistic diagnoses. While Tool A provides significant advancements in PET/CT, such as 'High sensitivity' and 'Improved small lesion detectability', the integrated functional and anatomical information from simultaneous PET/MR offers a distinct clinical advantage.

Pricing & Value

Discovery MI Gen2

Tool A provides some pricing transparency by listing a range for refurbished systems, giving potential buyers a starting point for budget considerations. In contrast, Tool B states its pricing is 'not publicly available', offering no initial financial guidance. This partial transparency from Tool A provides better value in the initial assessment phase.

Enterprise Readiness

Discovery MI Gen2

GE HealthCare, the manufacturer of Tool A, is a globally recognized and long-established leader in medical imaging, implying a mature and extensive enterprise support ecosystem, including robust service networks and integration capabilities. While Tool B's manufacturer, Shanghai United Imaging Healthcare Co., is a significant player with FDA clearance, GE's long-standing global footprint generally suggests a more proven and comprehensive enterprise readiness for large healthcare systems.

Innovation

uPMR 790

Tool B's simultaneous PET/MR imaging represents a more fundamental and transformative innovation by integrating two powerful diagnostic modalities into a single, concurrent acquisition. While Tool A incorporates advanced deep-learning AI and detector technologies to enhance PET/CT, Tool B's multimodal integration offers a more significant leap in imaging approach and data acquisition.

Support & Docs

Discovery MI Gen2

Given that neither JSON provides specific details on support or documentation, we rely on general industry knowledge. GE HealthCare, as a global leader in medical technology, is expected to have a more extensive and established global support network, comprehensive training programs, and robust documentation for its complex imaging systems compared to Shanghai United Imaging Healthcare Co., which, while growing, may not have as universally mature support infrastructure.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Discovery MI Gen2 uPMR 790
System Type Digital PET/CT system HD TOF PET/MR system
Company GE HealthCare Shanghai United Imaging Healthcare Co.
Core Imaging Modalities PET/CT PET/MRI
Detector/Platform Technology LightBurst Digital Detector HD TOF PET platform with digital silicon photomultipliers (SiPMs) and LYSO crystals
Axial Field of View (FOV) up to 30 cm Large 32cm
Key Imaging Resolution/Detectability Improved small lesion detectability (up to 41% increase) Industry-leading 2.8 mm NEMA PET spatial resolution
Advanced Image Reconstruction/Acquisition TrueFidelityu2122 deep-learning based image reconstruction, Q.Clear quantitation United Compressed Sensing (uCSu00ae 2.0) for ultra-fast MR acquisition, AI-assisted Compressed Sensing (uAIFI ACS)

Videos

Demos, reviews, and walkthroughs featuring Discovery MI Gen2 and uPMR 790.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Discovery MI Gen2 is a next-generation digital PET/CT system, combining PET and CT imaging for superior diagnostic imaging. In contrast, the uPMR 790 is an advanced HD TOF PET/MR system, offering simultaneous PET and MRI imaging for clinical and research applications.
The Discovery MI Gen2 utilizes deep-learning AI for TrueFidelityu2122 image reconstruction and Q.Clear quantitation, which aids in accurate SUV measurements and noise reduction. The uPMR 790 incorporates AI-enhanced workflows, including intelligent positioning, bed planning, and attenuation correction, and features AI-assisted Compressed Sensing (uAIFI ACS) for optimized MRI speed and image quality.
The Discovery MI Gen2 boasts high sensitivity, with up to a 125% increase, and improved small lesion detectability, showing up to a 41% increase. The uPMR 790 offers an industry-leading 2.8 mm NEMA PET spatial resolution, which significantly improves quantitative accuracy and small lesion detectability.
Yes, the Discovery MI Gen2 includes a MotionFree digital respiratory motion management solution to ensure clear images. The uPMR 790 also highlights intelligent workflow features that include precise attenuation correction algorithms and improved motion correction.
The uPMR 790 explicitly includes a 'uSync Research platform' for advanced PET/MR research opportunities, such as simultaneous tracking of PET and MR tracers. While the Discovery MI Gen2 is designed to accelerate research and enhance clinical work, it does not detail a dedicated research platform in the same way.
The Discovery MI Gen2 features a LightBurst Digital Detector with a scalable axial FOV up to 30 cm. The uPMR 790 offers a large 32cm axial field-of-view (FOV) for comprehensive imaging.
AI Tool Finder
AI-powered search. Results may not be comprehensive.